ABCDEFGHIJKL
1
2022202320242025202620272028202920302022-2030
2
Population screened with x-rays (millions)0.20.64.54.51.30.60.60.60.6
3
4
Mortality Averted
5
Deaths averted per million population over 20 years, Shrestha 2021
1,3801,3801,3801,3801,3801,3801,3801,3801,380
6
Internal validity adjustment0.500.500.500.500.500.500.500.500.50
7
Deaths averted per million population over 20 years, adjusted
690690690690690690690690690
8
Total direct deaths averted1494473,1243,124894447447447447
9
10
Sequelae-induced deaths averted per death averted 0.740.740.740.740.740.740.740.740.74
11
Total sequelae-induced deaths averted1103312,3122,312662331331331331
12
Total deaths averted 2597785,4365,4361,55677877877877816,577
13
Moral value of a death averted707070707070707070
14
Total units of value from mortality averted18,15354,459380,509380,509108,91854,45954,45954,45954,4591,160,385
15
16
Morbidity Averted
17
Cases of active TB treated/averted per million population over 20 years
10,10010,10010,10010,10010,10010,10010,10010,10010,10090,900
18
Cases of active TB treated/averted over 20 years 2,1826,54545,72945,72913,0906,5456,5456,5456,545
19
Disability weight per TB case0.3330.3330.3330.3330.3330.3330.3330.3330.333
20
Length of illness (years)222222222
21
Years of healthy life lost due to disability (YLDs) averted
726217915228152284359217921792179217946,438
22
Moral value of a YLD averted2.32.32.32.32.32.32.32.32.3
23
Total units of value from morbidity averted167150133502435024100255013501350135013106,807
24
25
Treatment Costs Averted
26
Costs per TB case (incurred by patients)$129$129$129$129$129$129$129$129$129
27
Baseline annual consumption per capita (in nominal USD)
$500$500$500$500$500$500$500$500$500
28
Per capita increase in ln(consumption) resulting from intervention
0.2300.2300.2300.2300.2300.2300.2300.2300.230
29
Value assigned to doubling consumption for one person for one year
111111111
30
Value assigned to increasing ln(consumption) by one unit for one person for one year
1.441.441.441.441.441.441.441.441.44
31
Units of value from medical costs averted per person, per year
0.3310.3310.3310.3310.3310.3310.3310.3310.331
32
Total units of value from medical costs averted3611084757175712167108410841084108423,089
33
34
Total value generated by the program, before leveraging/funging
20,18560,555423,103423,103121,11160,55560,55560,55560,5551,290,280
35
Value from deaths averted90%
36
Value from morbidity averted8%
37
Value from treatment costs averted2%
38
39
Leverage/Funging
40
Total leveraged costs $ 193,386 $ 721,376 $ 21,068,452 $ 21,068,452 $ 1,253,684 $ 459,214 $ 338,176 $ 250,574 $ 186,302
41
Counterfactual cost-effectiveness of leveraged costs (x cash)
222222222
42
Counterfactual value of leveraged costs, per dollar0.00670.00670.00670.00670.00670.00670.00670.00670.0067
43
Counterfactual value of leveraged costs, total1,2964,833141,159141,1598,4003,0772,2661,6791,248305,115
44
Total value generated by the program, after leveraging/funging
18,88955,722281,945281,945112,71157,47958,29058,87759,307985,165
45
% change in cost-effectiveness from Leverage/Funging-6%-8%-33%-33%-7%-5%-4%-3%-2%-24%
46
47
Costs
48
 - CAPEX Budget$11,334,920$1,223,548$12,558,468
49
 - OPEX Budget$1,077,722$5,570,868$18,841,757$19,122,248$5,983,584$4,515,802$3,868,603$3,916,912$3,904,755$66,802,251
50
51
Bottom line cost-effectiveness (x cash)3.7
52
53